Study to Determine the Pharmacokinetics of Product 0405
NCT02176577
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Business Reasons
Conditions
Atopic Dermatitis
Interventions
DRUG:
Product 0405
Sponsor
Fougera Pharmaceuticals Inc.